Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer

Nicole Pinto¹, Morgan Black¹, Krupal Patel¹, John Yoo², Joe S Mymryk³, John W Barrett⁴, Anthony C Nichols⁵

Affiliations

¹ Department of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, Canada N6A 3K7.
² Department of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, Canada N6A 3K7 ; London Regional Cancer Program, London, ON, Canada N6C 2R6 ; Department of Oncology, The University of Western Ontario, London, ON, Canada N6A 3K7.
³ London Regional Cancer Program, London, ON, Canada N6C 2R6 ; Department of Oncology, The University of Western Ontario, London, ON, Canada N6A 3K7 ; Lawson Health Research Institute, London, ON, Canada N6C 2R5 ; Department of Microbiology and Immunology, The University of Western Ontario, London, ON, Canada N6A 3K7.
⁴ Department of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, Canada N6A 3K7 ; London Regional Cancer Program, London, ON, Canada N6C 2R6 ; Department of Oncology, The University of Western Ontario, London, ON, Canada N6A 3K7 ; Lawson Health Research Institute, London, ON, Canada N6C 2R5.
⁵ Department of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, Canada N6A 3K7 ; London Regional Cancer Program, London, ON, Canada N6C 2R6 ; Department of Oncology, The University of Western Ontario, London, ON, Canada N6A 3K7 ; Lawson Health Research Institute, London, ON, Canada N6C 2R5 ; Department of Microbiology and Immunology, The University of Western Ontario, London, ON, Canada N6A 3K7.

PMID: 25276134
PMCID: PMC4170827
DOI: 10.1155/2014/936285

Review

Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer

Nicole Pinto et al. J Oncol. 2014.

. 2014:2014:936285.

doi: 10.1155/2014/936285. Epub 2014 Sep 7.

Authors

Nicole Pinto¹, Morgan Black¹, Krupal Patel¹, John Yoo², Joe S Mymryk³, John W Barrett⁴, Anthony C Nichols⁵

Affiliations

¹ Department of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, Canada N6A 3K7.
² Department of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, Canada N6A 3K7 ; London Regional Cancer Program, London, ON, Canada N6C 2R6 ; Department of Oncology, The University of Western Ontario, London, ON, Canada N6A 3K7.
³ London Regional Cancer Program, London, ON, Canada N6C 2R6 ; Department of Oncology, The University of Western Ontario, London, ON, Canada N6A 3K7 ; Lawson Health Research Institute, London, ON, Canada N6C 2R5 ; Department of Microbiology and Immunology, The University of Western Ontario, London, ON, Canada N6A 3K7.
⁴ Department of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, Canada N6A 3K7 ; London Regional Cancer Program, London, ON, Canada N6C 2R6 ; Department of Oncology, The University of Western Ontario, London, ON, Canada N6A 3K7 ; Lawson Health Research Institute, London, ON, Canada N6C 2R5.
⁵ Department of Otolaryngology, Head & Neck Surgery, The University of Western Ontario, London, ON, Canada N6A 3K7 ; London Regional Cancer Program, London, ON, Canada N6C 2R6 ; Department of Oncology, The University of Western Ontario, London, ON, Canada N6A 3K7 ; Lawson Health Research Institute, London, ON, Canada N6C 2R5 ; Department of Microbiology and Immunology, The University of Western Ontario, London, ON, Canada N6A 3K7.

PMID: 25276134
PMCID: PMC4170827
DOI: 10.1155/2014/936285

Abstract

Thyroid cancer is an endocrine malignancy with an incidence rate that has been increasing steadily over the past 30 years. While well-differentiated subtypes have a favorable prognosis when treated with surgical resection and radioiodine, undifferentiated subtypes, such as anaplastic thyroid cancer (ATC), are far more aggressive and have a poor prognosis. Conventional therapies (surgical resection, radiation, chemotherapy, and radioiodine) have been utilized for treatment of ATC, yet these treatments have not significantly improved the overall mortality rate. As cancer is a genetic disease, genetic alterations such as mutations, fusions, activation of oncogenes, and silencing of tumor suppressors contribute to its aggressiveness. With the use of next-generation sequencing and the Cancer Genome Atlas, mutation-directed therapy is recognized as the upcoming standard of care. In this review, we highlight the known genetic landscape of ATC and the need for a comprehensive genetic characterization of this disease in order to identify additional therapeutic targets to improve patient outcomes.

PubMed Disclaimer

References

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer Journal for Clinicians. 2009;59(4):225–249. - PubMed
1. Mazeh H, Benavidez J, Poehls JL, Youngwirth L, Chen H, Sippel RS. In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. Thyroid. 2012;22(1):3–8. - PubMed
1. National Cancer Institute at the National Institutes of Health. http://www.cancer.gov/cancertopics/types/thyroid.
1. Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nature Reviews Endocrinology. 2011;7(10):569–580. - PubMed
1. Ringel MD, Ladenson PW. Controversies in the follow-up and management of well-differentiated thyroid cancer. Endocrine-Related Cancer. 2004;11(1):97–116. - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer

Affiliations

Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer

Authors

Affiliations

Abstract

References

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources

Research Materials

Miscellaneous